Arbor Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, MA – January 4, 2023 -

Arbor Biotechnologies^®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that its Chief Executive Officer, Devyn Smith, Ph.D., will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 1:30 p.m. PT.